The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 26, 2020

Filed:

Jan. 28, 2019
Applicant:

Sederma, Le Perray en Yvelines, FR;

Inventors:

Olivier Peschard, Saint Prest, FR;

Philippe Mondon, Montrouge, FR;

Assignee:

Sederma, , FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 5/103 (2006.01); C07K 5/093 (2006.01); C07K 5/087 (2006.01); C07K 5/097 (2006.01); C07K 5/078 (2006.01); C07K 5/062 (2006.01); A61K 38/00 (2006.01); A61Q 19/02 (2006.01); A61K 8/64 (2006.01); A61Q 5/10 (2006.01); A61Q 19/04 (2006.01); A61Q 19/08 (2006.01); C07K 5/083 (2006.01); A61Q 19/00 (2006.01);
U.S. Cl.
CPC ...
A61K 8/64 (2013.01); A61Q 5/10 (2013.01); A61Q 19/007 (2013.01); A61Q 19/04 (2013.01); A61Q 19/08 (2013.01); C07K 5/06026 (2013.01); C07K 5/06165 (2013.01); C07K 5/081 (2013.01); C07K 5/0806 (2013.01); C07K 5/0808 (2013.01); C07K 5/0812 (2013.01); C07K 5/0819 (2013.01); C07K 5/0821 (2013.01); C07K 5/1008 (2013.01); A61K 38/00 (2013.01); A61K 2800/74 (2013.01);
Abstract

The invention is directed to the use of at least one peptide of formula: X-(Xaa)-Pro*-(Xaa)-Y (I) With: —n=0, 1 or 2; —m=0 or 1 and if m=0 then n≠0 —Xaais: —An hydrophobic aminoacid selected from Alanine (Ala, A), Valine (Val, V), Methionine (Met, M), Leucine (Leu, L), Isoleucine (Ile, I), Phenylalanine (Phe, F), Proline (Pro, P) and analogues and derivatives thereof; —A polar aminoacid selected from Serine (Ser, S), Threonine (Thr, T), Tyrosine (Tyr, Y), Asparagine (Asn, N), Glutamine (Gln, Q) and analogues and derivatives thereof; —or Glycine (Gly, G); When n=2 the two aminoacids Xaacan be the same or different; —Xaais: —An hydrophobic aminoacid selected from Alanine (Ala, A), Valine (Val, V), Methionine (Met, M), Leucine (Leu, L), Isoleucine (Ile, I), Phenylalanine (Phe, F), Proline (Pro, P) and analogues and derivatives thereof; —A basic aminoacid selected from Arginine (Arg, R), Lysine (Lys, K) and Histidine (His, H) and analogues and derivatives thereof; —Glycine (Gly, G) or Serine (Ser, S); —At the N terminal end of the peptide, X is selected from H, —CO—Rand —SO—R; —At the C terminal end of the peptide, Y is selected from OH, OR, NH, NHRor NRR, Rand Rbeing independently from each other, selected from an alkyle, aryle, aralkyle, alkylaryl, alkoxy and aryloxy group, that can be linear, branched, cyclic, poly-cyclic, non-saturated, hydroxylated, carbonylated, phosphorylated and/or sulphured, with the possibility to have in said group skeleton a O, S and/or N heteroatom; —Pro* corresponding to a Proline, an analogue or derivative thereof; Excluding the peptides where X═H and Y═OH, for a non therapeutical cosmetic pro-pigmenting treatment of skin. The invention also encompasses new tripeptides of formula (I) suitable for a non therapeutical cosmetic treatment of skin.


Find Patent Forward Citations

Peschard, Olivier. (2020). Pro-pigmenting peptides (U.S. Patent No. 10660839). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10660839

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…